Proactive Investors - Run By Investors For Investors

Cellmid managing director and CEO buys shares on market

The company sells hair loss products in Australia, Japan and the U.S.
picture of Maria Halasz during stocktube interview
Halasz paid over $35,000 for her shares

Cellmid Limited (ASX:CDY) has been shown support from its board and management as Maria Halasz, managing director and CEO, has increased her holding in the company.

Halasz purchased 70,000 shares through on-market trades to increase her total direct and indirect holding to over 1.38 million shares.

READ: Cellmid achieves record quarterly sales for its hair care products

The company finished the recent December quarter with $3.5 million in cash including $1.42 million in receipts from customers.

View full CDY profile View Profile

Cellmid Ltd Timeline

Related Articles

Surgery
February 20 2019
Earlier this month, Tissue Regenix reported full-year results showing revenues more than doubled last year to £11.6mln, up from £5.2mln a year earlier
1538160791_petri-dishes.jpg
September 28 2018
The biotech group revealed it had brought in $9.1mln via an oversubscribed placing
A stomach adenocarcinoma
February 13 2019
The company’s B-cell peptide cancer vaccines have shown promise in pre-clinical and early-stage study.

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use